Back to All Events

Bill Doyle, Executive Chairman of Novocure, and Dekel Gelbman, CEO of FDNA

  • Harvard Business School, Aldrich 210 (map)

Bill Doyle is an experienced healthcare executive whose experiences include working at Pershing Square Capital management, running several divisions at Johnson & Johnson, and is currently on the board of startup Blink Health, just to name a few of his accomplishments.

Dekel Gelman is CEO of DNA, whose technology is used by 70% of the world’s geneticists in over 130 countries. FDNA’s next-generation phenotyping (NGP) technologies analyze complex human physiological data to produce actionable genomic insights.